Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival.

Mario MandalaJames LarkinPaolo Antonio AsciertoMichele Del VecchioHelen J GogasC Lance CoweyAna AranceStéphane DalleMichael SchenkerJean-Jacques GrobVanna Chiarion-SileniIvan Marquez-RodasMarcus O ButlerAnna Maria Di GiacomoJose LutzkyLuis De La Cruz-MerinoVictoria AtkinsonPetr ArenbergerAndrew HillLeslie FecherMichael MillwardNikhil I KhushalaniVeerle de PrilMaurice LoboJeffrey S Weber

Published in: Journal for immunotherapy of cancer (2022)

NCT02388906.

Keyphrases

free survival
early stage
skin cancer
type diabetes
metabolic syndrome
skeletal muscle